SCHEESSELE WILLIAM JOHN (Chief Commercial Officer) purchased 41.8% of their position (6.49K shares) of HUMACYTE, INC. on the open market
Open‑market purchase worth $10.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 4/15/2025ACC: 0001818382-25-000052
Officer· Chief Commercial Officer
Since Aug 2021
+6.49K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.49K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.49K
Price / share
$1.54
Trade value
$10K
% of position
41.8%
4/14/2025
15.53K→22.02K
Total
Net shares
+6.49K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/14/2025 | P · Purchase | +6.49K | $1.54 | $10K | 41.8% | 15.53K | 22.02K |
| Total | +6.49K | $10K | ||||||
Derivative Transactions0
No derivative transactions reported